![Health Ministry permits import of drugs through Cochin and Thiruvananthapuram airports](https://lexplosion.in/wp-content/uploads/2024/06/Health-Ministry-permits-import-of-drugs-through-Cochin-and-Thiruvananthapuram-airports.jpg)
![Health Ministry permits import of drugs through Cochin and Thiruvananthapuram airports](https://lexplosion.in/wp-content/uploads/2024/06/Health-Ministry-permits-import-of-drugs-through-Cochin-and-Thiruvananthapuram-airports.jpg)
![Department of Pharmaceuticals mandates self-declaration for compliance with new Uniform Code for Pharmaceutical Marketing Practices (UCPMP) by 30th June, 2024](https://lexplosion.in/wp-content/uploads/2024/06/Department-of-Pharmaceuticals-mandates-self-declaration-for-compliance-with-new.jpg)
Department of Pharmaceuticals mandates self-declaration for compliance with new Uniform Code for Pharmaceutical Marketing Practices (UCPMP) by 30th June, 2024
The Department of Pharmaceuticals has directed pharmaceutical companies to submit self-declaration... Read More![Stakeholders in medical devices sector urged by CDSCO to ensure timely payment of retention fees to maintain validity of licenses and certificates](https://lexplosion.in/wp-content/uploads/2024/05/2-2.jpg)
Stakeholders in medical devices sector urged by CDSCO to ensure timely payment of retention fees to maintain validity of licenses and certificates
The Central Drugs Standard Control Organisation (“CDSCO”) has reiterated that licenses for... Read More![CDSCO allows operational continuity for importers and manufacturers of Class C & D Medical Devices; pending pre-September 2023 licensing applications deemed valid until 16th August, 2024 or CLA decision](https://lexplosion.in/wp-content/uploads/2024/05/CDSCO-allows-operational-continuity-for-importers-and-manufacturers-of-Class-C-D-Medical-Devices.jpg)
CDSCO allows operational continuity for importers and manufacturers of Class C & D Medical Devices; pending pre-September 2023 licensing applications deemed valid until 16th August, 2024 or CLA decision
The Central Drugs Standard Control Organization (CDSCO) has issued a Circular in response to... Read More![NOC for manufacture of unapproved/approved new drugs/banned drugs (solely for export) to be obtained from Zonal offices via Sugam Portal, effective from 15th May 2024: CDSCO](https://lexplosion.in/wp-content/uploads/2024/05/NOC-for-manufacture-of-unapproved-approved-new-drugs.jpg)
NOC for manufacture of unapproved/approved new drugs/banned drugs (solely for export) to be obtained from Zonal offices via Sugam Portal, effective from 15th May 2024: CDSCO
The Central Drugs Control Standards Organization (CDSCO) has communicated to drug controllers of... Read More![Public comments invited till 25th April, 2024 on draft of revised guidance for industry to align with the New Drugs and Clinical Trials (NDCT) Rules, 2019 and Sugam application process (Version 1.2)](https://lexplosion.in/wp-content/uploads/2024/04/Public-comments-invited-till-25th-April-2024-on-draft-of-revised-guidance-for-industry-to-align.jpg)